Hualan Biological Engineering Inc. (SHE:002007)
China · Delayed Price · Currency is CNY 15.86
-0.33 (-2.04%)
Jan 28, 2026, 9:55 AM CST
SHE:002007 Revenue
Hualan Biological Engineering had revenue of 1.58B CNY in the quarter ending September 30, 2025, a decrease of -14.00%. This brings the company's revenue in the last twelve months to 4.27B, down -13.26% year-over-year. In the year 2024, Hualan Biological Engineering had annual revenue of 4.38B, down -18.02%.
Revenue (ttm)
4.27B
Revenue Growth
-13.26%
P/S Ratio
6.93
Revenue / Employee
1.06M
Employees
4,012
Market Cap
29.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.38B | -962.68M | -18.02% |
| Dec 31, 2023 | 5.34B | 824.89M | 18.26% |
| Jan 1, 2023 | 4.52B | 80.78M | 1.82% |
| Jan 1, 2022 | 4.44B | -587.01M | -11.69% |
| Dec 31, 2020 | 5.02B | 1.32B | 35.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DaShenLin Pharmaceutical Group | 26.83B |
| Shanghai RAAS Blood Products | 7.95B |
| Beijing Tiantan Biological Products | 6.42B |
| Asymchem Laboratories (Tianjin) | 6.29B |
| Yili Chuanning Biotechnology | 4.74B |
| Xiamen Amoytop Biotech | 3.34B |
| Sinocelltech Group | 1.89B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 1.37B |